PET/MR scan for breast cancer using fluorocholine
Part of Cancer, Skin clinical trials.
This study uses a special imaging scan (PET/MR) with a tracer called fluorocholine to see if it can help evaluate breast cancer before treatment or before surgery. It is for women who are newly diagnosed with breast cancer and will either have chemotherapy before surgery or go straight to surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 25 to 75
- You had a breast cancer diagnosis from a biopsy in the past 3 months
- You will receive chemotherapy before surgery, or you will have surgery without pre-surgery chemotherapy
- You are able to walk and care for yourself (ECOG score 0-2) and expected to live at least 3 months
- You are not pregnant, breastfeeding, or planning to become pregnant
- You do not have kidney problems, claustrophobia, or certain metal implants like a pacemaker or aneurysm clip
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether a PET/CT scan using a tracer called 18F-fluorocholine can better identify tumors. It may help doctors more accurately find and characterize tumors to guide treatment.
This study tests whether a new type of PET/MRI scan can help doctors see how well breast cancer treatment is working. It is a platform study, meaning it can evaluate different treatments, but the focus is on using this advanced imaging to monitor response.
This early-phase study looks at how well PET/MRI scans can monitor treatment response in people with HER2-positive breast cancer before surgery. You may be asked to undergo specific scans during “neoadjuvant” therapy (treatment given before the main operation).
This study uses a special PET scan to see if chemotherapy can damage the heart early. The goal is to find problems sooner so doctors can protect your heart during cancer treatment.
This trial is studying if a special PET/MRI scan using a tracer called 18F FES can help doctors decide the best treatment for people with Luminal A or hormone-receptor-positive lobular breast cancer. The scan looks at estrogen receptors to see if your cancer might respond to hormone therapy.
This trial tests a new PET/MRI scan (using a special tracer called 18F-FFNP) to see how it images progesterone-receptor-positive breast cancer before surgery. You would get the scan and then have your planned surgery.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.